![Donna Best](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Donna Best
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Triad Life Sciences, Inc.
![]() Triad Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million. | Directeur/Bestuurslid | - | - |
Operationeel Directeur | - | - |
Loopbaan van Donna Best
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Triad Life Sciences, Inc.
![]() Triad Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million. | Health Technology |
- Beurs
- Insiders
- Donna Best
- Ervaring